You are here
ABOUT NIBIB
Lixin Lang, Ph.D.
Staff Scientist
BG 10 RM B2C315 10 CENTER DR BETHESDA MD 20814
Telephone:
301-451-3532
Email:
Program Area:
Biography
Dr. Lang received his B.S. in Radiation Chemistry from the University of Technology of China in 1983; a Master of Science in Radiochemistry from the Shanghai Institute of Nuclear Research in 1986; and his Ph.D. in Radiopharmaceutical Chemistry from the University of Missouri-Columbia in 1992. He began his NIH career as an international fellow in the Clinical Center PET Department in 1992, and accepted a staff scientist position in 1998. Dr. Lang joined NIBIB in October 2004 when the Clinical Center Radiochemistry Section was realigned and became an organizational component of NIBIB’s Intramural Science Program.
Selected Publications
Most Recent
- First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using 68Ga-IRDye800CW-BBN. Li D, Zhang J, Chi C, Xiao X, Wang J, Lang L, Ali I, Niu G, Zhang L, Tian J, Ji N, Zhu Z, Chen X. Theranostics. 2018.
- Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes. Zhou M, Tang Q, Lang L, Xing J, Tatsuoka K. Stat Med. 2018 Jun 30.
- 68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer. Zhang J, Mao F, Niu G, Peng L, Lang L, Li F, Ying H, Wu H, Pan B, Zhu Z, Chen X. Theranostics. 2018.
- Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26. Cheng S, Lang L, Wang Z, Jacobson O, Yung B, Zhu G, Gu D, Ma Y, Zhu X, Niu G, Chen X. Bioconjug Chem. 2018 Feb 21.
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. Zhu G, Lynn GM, Jacobson O, Chen K, Liu Y, Zhang H, Ma Y, Zhang F, Tian R, Ni Q, Cheng S, Wang Z, Lu N, Yung BC, Wang Z, Lang L, Fu X, Jin A, Weiss ID, Vishwasrao H, Niu G, Shroff H, Klinman DM, Seder RA, Chen X. Nat Commun. 2017 Dec 5.
- PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients. Zhang J, Niu G, Fan X, Lang L, Hou G, Chen L, Wu H, Zhu Z, Li F, Chen X. J Nucl Med. 2018 Jun.
- Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography. Chen H, Tong X, Lang L, Jacobson O, Yung BC, Yang X, Bai R, Kiesewetter DO, Ma Y, Wu H, Niu G, Chen X. Theranostics. 2017.
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH Rd, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I. Lancet. 2017 Jun 24.
- Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema. Long X, Zhang J, Zhang D, Gao C, Chi C, Yang E, Xue H, Lang L, Niu G, Zhu Z, Li F, Chen X. Eur J Nucl Med Mol Imaging. 2017 Aug.
- Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. Zhang J, Niu G, Lang L, Li F, Fan X, Yan X, Yao S, Yan W, Huo L, Chen L, Li Z, Zhu Z, Chen X. J Nucl Med. 2017 Feb.
- A photothermally responsive nanoprobe for bioimaging based on Edman degradation. Liu Y, Wang Z, Zhang H, Lang L, Ma Y, He Q, Lu N, Huang P, Liu Y, Song J, Liu Z, Gao S, Ma Q, Kiesewetter DO, Chen X. Nanoscale. 2016 May 19.
- Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding. Chen H, Wang G, Lang L, Jacobson O, Kiesewetter DO, Liu Y, Ma Y, Zhang X, Wu H, Zhu L, Niu G, Chen X. Theranostics. 2016.
- Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment. Liu Y, Wang G, Zhang H, Ma Y, Lang L, Jacobson O, Kiesewetter DO, Zhu L, Gao S, Ma Q, Chen X. Bioconjug Chem. 2016 Jan 20.
- 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients. Zhang J, Li D, Lang L, Zhu Z, Wang L, Wu P, Niu G, Li F, Chen X. J Nucl Med. 2016 Jan.
- 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer. Zheng K, Liang N, Zhang J, Lang L, Zhang W, Li S, Zhao J, Niu G, Li F, Zhu Z, Chen X. J Nucl Med. 2015 Dec.
2018
- First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using 68Ga-IRDye800CW-BBN. Li D, Zhang J, Chi C, Xiao X, Wang J, Lang L, Ali I, Niu G, Zhang L, Tian J, Ji N, Zhu Z, Chen X. Theranostics. 2018.
- Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes. Zhou M, Tang Q, Lang L, Xing J, Tatsuoka K. Stat Med. 2018 Jun 30.
- 68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer. Zhang J, Mao F, Niu G, Peng L, Lang L, Li F, Ying H, Wu H, Pan B, Zhu Z, Chen X. Theranostics. 2018.
- Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26. Cheng S, Lang L, Wang Z, Jacobson O, Yung B, Zhu G, Gu D, Ma Y, Zhu X, Niu G, Chen X. Bioconjug Chem. 2018 Feb 21.
- PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients. Zhang J, Niu G, Fan X, Lang L, Hou G, Chen L, Wu H, Zhu Z, Li F, Chen X. J Nucl Med. 2018 Jun.
2017
- Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. Zhu G, Lynn GM, Jacobson O, Chen K, Liu Y, Zhang H, Ma Y, Zhang F, Tian R, Ni Q, Cheng S, Wang Z, Lu N, Yung BC, Wang Z, Lang L, Fu X, Jin A, Weiss ID, Vishwasrao H, Niu G, Shroff H, Klinman DM, Seder RA, Chen X. Nat Commun. 2017 Dec 5.
- Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography. Chen H, Tong X, Lang L, Jacobson O, Yung BC, Yang X, Bai R, Kiesewetter DO, Ma Y, Wu H, Niu G, Chen X. Theranostics. 2017.
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH Rd, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I. Lancet. 2017 Jun 24.
- Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema. Long X, Zhang J, Zhang D, Gao C, Chi C, Yang E, Xue H, Lang L, Niu G, Zhu Z, Li F, Chen X. Eur J Nucl Med Mol Imaging. 2017 Aug.
- Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. Zhang J, Niu G, Lang L, Li F, Fan X, Yan X, Yao S, Yan W, Huo L, Chen L, Li Z, Zhu Z, Chen X. J Nucl Med. 2017 Feb.
2016
- A photothermally responsive nanoprobe for bioimaging based on Edman degradation. Liu Y, Wang Z, Zhang H, Lang L, Ma Y, He Q, Lu N, Huang P, Liu Y, Song J, Liu Z, Gao S, Ma Q, Kiesewetter DO, Chen X. Nanoscale. 2016 May 19.
- Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding. Chen H, Wang G, Lang L, Jacobson O, Kiesewetter DO, Liu Y, Ma Y, Zhang X, Wu H, Zhu L, Niu G, Chen X. Theranostics. 2016.
- Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment. Liu Y, Wang G, Zhang H, Ma Y, Lang L, Jacobson O, Kiesewetter DO, Zhu L, Gao S, Ma Q, Chen X. Bioconjug Chem. 2016 Jan 20.
- 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients. Zhang J, Li D, Lang L, Zhu Z, Wang L, Wu P, Niu G, Li F, Chen X. J Nucl Med. 2016 Jan.
2015
- 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer. Zheng K, Liang N, Zhang J, Lang L, Zhang W, Li S, Zhao J, Niu G, Li F, Zhu Z, Chen X. J Nucl Med. 2015 Dec.
- Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB. Zhang J, Lang L, Zhu Z, Li F, Niu G, Chen X. J Nucl Med. 2015 Oct.
- (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases. Yu C, Pan D, Mi B, Xu Y, Lang L, Niu G, Yang M, Wan W, Chen X. Eur J Nucl Med Mol Imaging. 2015 Dec.
- Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET. Guo N, Zhang F, Zhang X, Guo J, Lang L, Kiesewetter DO, Niu G, Li Q, Chen X. Mol Imaging Biol. 2015 Dec.
- In vivo albumin labeling and lymphatic imaging. Wang Y, Lang L, Huang P, Wang Z, Jacobson O, Kiesewetter DO, Ali IU, Teng G, Niu G, Chen X. Proc Natl Acad Sci U S A. 2015 Jan 6.
2014
- In Vivo Labeling of Serum Albumin for PET. Niu G, Lang L, Kiesewetter DO, Ma Y, Sun Z, Guo N, Guo J, Wu C, Chen X. J Nucl Med. 2014 Jul.
- Longitudinal PET imaging of muscular inflammation using 18F-DPA-714 and 18F-Alfatide II and differentiation with tumors. Wu C, Yue X, Lang L, Kiesewetter DO, Li F, Zhu Z, Niu G, Chen X. Theranostics. 2014.
- Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages. Lang L, Ma Y, Kiesewetter DO, Chen X. Mol Pharm. 2014 Nov 3.
- Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity. Zhu L, Ma Y, Kiesewetter DO, Wang Y, Lang L, Lee S, Niu G, Chen X. ACS Chem Biol. 2014 Feb 21.
- (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy. Guo J, Guo N, Lang L, Kiesewetter DO, Xie Q, Li Q, Eden HS, Niu G, Chen X. J Nucl Med. 2014 Jan.
- Comparison of three dimeric 18F-AlF-NOTA-RGD tracers. Guo J, Lang L, Hu S, Guo N, Zhu L, Sun Z, Ma Y, Kiesewetter DO, Niu G, Xie Q, Chen X. Mol Imaging Biol. 2014 Apr.
2013
- Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas. Yue X, Kiesewetter DO, Guo J, Sun Z, Zhang X, Zhu L, Niu G, Ma Y, Lang L, Chen X. Bioconjug Chem. 2013 Jul 17.
- First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. Wan W, Guo N, Pan D, Yu C, Weng Y, Luo S, Ding H, Xu Y, Wang L, Lang L, Xie Q, Yang M, Chen X. J Nucl Med. 2013 May.
- One-step and one-pot-two-step radiosynthesis of cyclo-RGD-(18)F-aryltrifluoroborate conjugates for functional imaging. Li Y, Guo J, Tang S, Lang L, Chen X, Perrin DM. Am J Nucl Med Mol Imaging. 2013.
2012
- PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury. Gao H, Kiesewetter DO, Zhang X, Huang X, Guo N, Lang L, Hida N, Wang H, Wang H, Cao F, Niu G, Chen X. J Nucl Med. 2012 Dec.
- Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab. Jagoda EM, Lang L, Bhadrasetty V, Histed S, Williams M, Kramer-Marek G, Mena E, Rosenblum L, Marik J, Tinianow JN, Merchant M, Szajek L, Paik C, Cecchi F, Raffensperger K, Jose-Dizon JM, Bottaro DP, Choyke P. J Nucl Med. 2012 Oct.
- Quantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue model. Guo N, Lang L, Li W, Kiesewetter DO, Gao H, Niu G, Xie Q, Chen X. PLoS One. 2012.
- Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model. Guo N, Lang L, Gao H, Niu G, Kiesewetter DO, Xie Q, Chen X. Mol Imaging Biol. 2012 Dec.
- Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Huang X, Zhang F, Lee S, Swierczewska M, Kiesewetter DO, Lang L, Zhang G, Zhu L, Gao H, Choi HS, Niu G, Chen X. Biomaterials. 2012 Jun.
- Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V. Hu S, Kiesewetter DO, Zhu L, Guo N, Gao H, Liu G, Hida N, Lang L, Niu G, Chen X. Mol Imaging Biol. 2012 Dec.
- Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS. Ma Y, Yang M, Gao H, Niu G, Yan Y, Lang L, Kiesewetter DO, Chen X. Amino Acids. 2012 Oct.
- PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2. Gao H, Lang L, Guo N, Cao F, Quan Q, Hu S, Kiesewetter DO, Niu G, Chen X. Eur J Nucl Med Mol Imaging. 2012 Apr.
- N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression. Li W, Lang L, Niu G, Guo N, Ma Y, Kiesewetter DO, Shen B, Chen X. Amino Acids. 2012 Sep.
- PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model. Li W, Niu G, Lang L, Guo N, Ma Y, Kiesewetter DO, Backer JM, Shen B, Chen X. Eur J Nucl Med Mol Imaging. 2012 Feb.
2011
- Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Lang L, Li W, Guo N, Ma Y, Zhu L, Kiesewetter DO, Shen B, Niu G, Chen X. Bioconjug Chem. 2011 Dec 21.
- New Methods for Labeling RGD Peptides with Bromine-76. Lang L, Li W, Jia HM, Fang DC, Zhang S, Sun X, Zhu L, Ma Y, Shen B, Kiesewetter DO, Niu G, Chen X. Theranostics. 2011.
- Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425. Bhattacharjee AK, Lang L, Jacobson O, Shinkre B, Ma Y, Niu G, Trenkle WC, Jacobson KA, Chen X, Kiesewetter DO. Nucl Med Biol. 2011 Aug.
- F-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging. Yang M, Gao H, Zhou Y, Ma Y, Quan Q, Lang L, Chen K, Niu G, Yan Y, Chen X. Theranostics. 2011.
- PET imaging of early response to the tyrosine kinase inhibitor ZD4190. Yang M, Gao H, Yan Y, Sun X, Chen K, Quan Q, Lang L, Kiesewetter D, Niu G, Chen X. Eur J Nucl Med Mol Imaging. 2011 Jul.
- [(76) Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor. Jagoda EM, Lang L, McCullough K, Contoreggi C, Kim BM, Ma Y, Rice KC, Szajek LP, Eckelman WC, Kiesewetter DO. Synapse. 2011 Sep.
- Automated radiochemical synthesis of [18F]FBEM: a thiol reactive synthon for radiofluorination of peptides and proteins. Kiesewetter DO, Jacobson O, Lang L, Chen X. Appl Radiat Isot. 2011 Feb.
- LC/MS evaluation of metabolism and membrane transport of bombesin peptides. Gu D, Ma Y, Niu G, Yan Y, Lang L, Aisa HA, Gao H, Kiesewetter DO, Chen X. Amino Acids. 2011 Feb.
2010
- Applications of LC-MS in PET radioligand development and metabolic elucidation. Ma Y, Kiesewetter DO, Lang L, Gu D, Chen X. Curr Drug Metab. 2010 Jul.
- Effects of early-life stress on serotonin(1A) receptors in juvenile Rhesus monkeys measured by positron emission tomography. Spinelli S, Chefer S, Carson RE, Jagoda E, Lang L, Heilig M, Barr CS, Suomi SJ, Higley JD, Stein EA. Biol Psychiatry. 2010 Jun 15.
2009
- Application of highly sensitive UPLC-MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [(18)F]FPWAY. Ma Y, Lang L, Reyes L, Tokugawa J, Jagoda EM, Kiesewetter DO. Nucl Med Biol. 2009 May.
- Synthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography. Kiesewetter DO, Lang L, Ma Y, Bhattacharjee AK, Gao ZG, Joshi BV, Melman A, de Castro S, Jacobson KA. Nucl Med Biol. 2009 Jan.
2007
- An automated one-step one-pot [(18)F]FCWAY synthesis: development and minimization of chemical impurities. Vuong BK, Kiesewetter DO, Lang L, Ma Y, Eckelman WC, Channing MA. Nucl Med Biol. 2007 May.
- Distribution of the 5-HT(1A) receptor antagonist [ (18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia. Tokugawa J, Ravasi L, Nakayama T, Lang L, Schmidt KC, Seidel J, Green MV, Sokoloff L, Eckelman WC. Eur J Nucl Med Mol Imaging. 2007 Feb.
2006
- Species differences in metabolites of PET ligands: serotonergic 5-HT1A receptor antagonists 3-trans-FCWAY and 3-cis-FCWAY. Ma Y, Lang L, Kiesewetter D, Jagoda E, Eckelman WC. Nucl Med Biol. 2006 Nov.
- Development of a controlled vocabulary and software application to analyze fruit shape variation in tomato and other plant species. Brewer MT, Lang L, Fujimura K, Dujmovic N, Gray S, van der Knaap E. Plant Physiol. 2006 May.
- Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635. Lang L, Jagoda E, Ma Y, Sassaman MB, Eckelman WC. Bioorg Med Chem. 2006 Jun 1.
- Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT. Jagoda EM, Lang L, Tokugawa J, Simmons A, Ma Y, Contoreggi C, Kiesewetter D, Eckelman WC. Synapse. 2006 May.
2005
- 5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, Reeves-Tyer P, Herscovitch P, Eckelman WC, Carson RE, Theodore WH. J Nucl Med. 2005 Jul.
- Differential effects of paroxetine on raphe and cortical 5-HT1A binding: a PET study in monkeys. Giovacchini G, Lang L, Ma Y, Herscovitch P, Eckelman WC, Carson RE. Neuroimage. 2005 Oct 15.
2004
- Purification of the precursor for the automated radiosynthesis of [18F]FCWAY by counter-current chromatography. Ma Y, Lang L, Kiesewetter DO, Vuong BK, Channing M, Ito Y, Eckelman WC. J Chromatogr A. 2004 Apr 23.
2003
- Application of LC-MS to the analysis of new radiopharmaceuticals. Ma Y, Kiesewetter D, Lang L, Eckelman WC. Mol Imaging Biol. 2003 Nov-Dec.
- Determination of [18F]FCWAY, [18F]FP-TZTP, and their metabolites in plasma using rapid and efficient liquid-liquid and solid phase extractions. Ma Y, Kiesewetter DO, Lang L, Der M, Huang B, Carson RE, Eckelman WC. Nucl Med Biol. 2003 Apr.
- Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs. Carson RE, Wu Y, Lang L, Ma Y, Der MG, Herscovitch P, Eckelman WC. J Cereb Blood Flow Metab. 2003 Feb.
2002
- Comparison of an 18F labeled derivative of vasoactive intestinal peptide and 2-deoxy-2-[18F]fluoro-D-glucose in nude mice bearing breast cancer xenografts. Jagoda EM, Aloj L, Seidel J, Lang L, Moody TW, Green S, Caraco C, Daube-Witherspoon M, Green MV, Eckelman WC. Mol Imaging Biol. 2002 Oct.
- Liquid chromatography-tandem mass spectrometry identification of metabolites of three phenylcarboxyl derivatives of the 5-HT(1A) antagonist, N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl) trans-4-fluorocyclohexanecarboxamide (FCWAY), produced by human and rat hepatocytes. Ma Y, Lang L, Kiesewetter DO, Eckelman WC. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Nov 15.
- Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI. J Immunol Methods. 2002 Feb 1.